Ultrathin films are able to be injected using minimally-invasive syringe needles and can be used as a platform to deliver molecular and cellular drugs. The use of shape-memory polymer also enables unprecedented temperature-dependent control to allow for adhesion and removal of the nanosheets on biological surfaces.
Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine. Free-standing polymeric ultrathin films, commonly referred to as polymeric nanosheets, are one of the commonly used platforms for syringe-injectable biomedical devices because of their flexibility and conformability.
These nanosheets are less than 1 micrometer in thickness, which is thinner than a strand of hair that is usually about 100 micrometers wide. They are a promising platform for drug delivery through needle-injection. Despite recent development in nanosheets technologies using polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA), polymeric nanosheets are yet to overcome several technical challenges to serve as an effective injectable platform: namely, (1) limitation in the size of nanosheets injectable through medical needles, (2) suboptimal mechanical robustness (e.g., ripping during injection), and (3) limited control over shape recovery and motion control after injection.
To overcome these limitations, researchers from Digital Manufacturing and Design (DManD) Centre at the Singapore University of Technology and Design (SUTD) developed nanosheets using polyurethane-based shape-memory polymer (SMP) and magnetic nanoparticles (MNP) to demonstrate unprecedented capabilities to handle nanosheets. SMP offers two unique mechanical characteristics – a large change in the Young’s moduli by the change in temperature, and shape-memory effect (SME) to recover the memorised shape.
In addition, the researchers demonstrated that the fabricated SMP nanosheets can be rendered magnetic with MNP to perform non-contact motion control using an external magnetic field. Specifically, the following four capabilities were demonstrated by using the 710 nm thick nanosheet with the glass transition temperature (Tg) of 25?C: (1) syringe-injectability through the medical needles, (2) self-expandability after ejection, (3) conformability and removability on the biological surfaces, and (4) guidability in an external magnetic field. These capabilities enable in vivo practical applications as a syringe-injectable platform.
As an added advantage, the change of the modulus by temperature offers a unique capability to control the adhesion and removal of the MNP-SMP nanosheet on the biological surfaces. This would have been difficult to achieve using conventional nanosheets having a constant modulus and has not been demonstrated previously.
Envisaging the syringe-injectable delivery of molecular drugs or cellular constructs into internal organs, the researchers added the MNP-SMP nanosheets with an additional layer of PLGA, which is best known as a biomaterial used for drug delivery, to extend the functionality as a carrier of molecular and cellular drugs. This can be done without compromising the demonstrated capabilities. SMP and MNP offered the same capabilities to the nanosheets containing an additional layer of PLGA, suggesting the vast potential of the developed nanosheets for drug and cell delivery.
“The MNP-SMP nanosheets can be further functionalized by loading or printing drugs, cells and electric circuits on the surface by integrating emerging printing technologies such as inkjet printing, 3D printing and bioprinting,” said Dr Kento Yamagishi from SUTD, the lead author of the paper.
“The MNP-SMP nanosheets will contribute to the development of advanced syringe-injectable medical devices as a platform to deliver drugs and cells to the specific site or lesion in the body for minimally invasive diagnosis and therapy,” added Principal Investigator, Assistant Professor Michinao Hashimoto from SUTD.
The Latest on: Syringe-injectable medical devices
[google_news title=”” keyword=”syringe-injectable medical devices” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Syringe-injectable medical devices
- Meet the medical device company that won a $100,000 business pitch competitionon May 10, 2024 at 9:00 am
A Metairie-based company that makes disposable devices to regulate the flow of medication won the Baton Rouge Entrepreneurship Week business pitch competition Thursday evening.
- Safety Syringes Market High Hopes for Future Revenues as Market Size Continues to Riseon May 9, 2024 at 4:31 pm
The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...
- Insulet misses first-quarter profit estimates as marketing costs weighon May 9, 2024 at 1:51 pm
Insulet Corp reported first-quarter profit that missed market expectations on Thursday, weighed by higher marketing expenses, sending shares of the medical device maker down 3.7% in extended trading.
- FDA clarifies definition of 'remanufacturing' for medical devices needing maintenanceon May 9, 2024 at 1:45 pm
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing maintenance or repair, advising that ...
- Guide: Optimizing Medical Injection Molding for Syringe Components and Beyondon May 6, 2024 at 2:01 pm
As demand for healthcare surges, the global syringe market is forecasted to reach $18.5 billion by 2026, with an estimated 7 billion additional units of global syringe production capacity required to ...
- 'Vampire Facials' Linked to HIV Cases—What to Know About the Cosmetic Procedureon May 6, 2024 at 11:43 am
At least three people have been infected with HIV after getting vampire facials at an unlicensed spa in New Mexico. Here's what you need to know.
- Smart Syringe Market Future of Market Size A Catalyst for Business Transformationon May 5, 2024 at 3:55 pm
Smart Syringe Market is valued approximately at USD 6.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2020-2027. Smart syringes are ...
- Best Medical Alert Systems Of 2024on May 2, 2024 at 7:39 am
Medical alert systems are important medical devices designed to assist in an emergency event by connecting users to a dispatcher who can send for assistance in the event of a medical emergency.
- FDA warns Cardinal Health on use of imported syringeson May 1, 2024 at 5:52 am
The U.S. Food and Drug Administration has warned health care giant Cardinal Health over sales of imported plastic syringes made by Jiangsu Shenli Medical Production Co. Ltd. that don't meet device ...
- Measles and rubella vaccine delivered via microarray patch shows promising resultson April 29, 2024 at 9:59 pm
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
via Bing News